US Patent Issued to ALFASIGMA on Feb. 24 for "Compound useful for the treatment of degenerative and inflammatory diseases" (Belgian Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,360, issued on Feb. 24, was assigned to ALFASIGMA S.P.A. (Bologna, Italy).

"Compound useful for the treatment of degenerative and inflammatory diseases" was invented by Christel Jeanne Marie Menet (Mechelen, Belgium) and Koen Kurt Smits (Boechout, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "A novel compound able to inhibit JAK is disclosed, that comprises a compound of Formula 1:The compound may be prepared as a pharmaceutical composition, and may be used for the treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune diseases, proliferative diseases, ...